miR-381-3p suppresses the proliferation of oral squamous cell carcinoma cells by directly targeting FGFR2

被引:5
作者
Yang, Xiao [1 ]
Ruan, Huibing [2 ]
Hu, Xi [1 ]
Cao, Anyi [3 ,4 ]
Song, Li [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Stomatol, 1 Minde St, Nanchang, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 2, Dept Orthopaed Surg, Nanchang, Jiangxi, Peoples R China
[3] Jinan Univ, Affiliated Huizhou Stomatol Hosp, Dept Orthodont, Huizhou, Guangdong, Peoples R China
[4] Huizhou Stomatol Hosp, Huizhou, Guangdong, Peoples R China
关键词
miR-381-3p; oral squamous cell carcinoma; FGFR2; proliferation; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; UP-REGULATION; TUMOR-GROWTH; CANCER; METASTASIS; EXPRESSION; INVASION; ADENOCARCINOMA; INHIBITOR;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutiple microRNAs are implicated in oral squamous cell carcinoma (OSCC), which is characterized by a high rate of proliferation and nodal metastasis. Data from the present study showed that miR-381-3p is significantly underexpressed in both OSCC tissues and cell lines. Overexpression of miR-381-3p led to marked suppression of proliferation and cell cycle progression of OSCC cells and promotion of apoptosis. Notably, fibroblast growth factor receptor 2 (FGFR2) was downregulated by miR-381-3p through direct interactions with its 3' untranslated region. Knockdown of FGFR2 recapitulated the growth suppressive effect of miR-381-3p. Conversely, restoring FGFR2 expression attenuated miR-381-3p-induced effects in OSCC cells. Expression patterns of miR-381-3p and FGFR2 were inversely correlated in OSCC tissues. Our collective results provide novel evidence that miR-381-3p acts as a tumor suppressor in OSCC by directly targeting FGFR2, thereby presenting a promising therapeutic target.
引用
收藏
页码:913 / 922
页数:10
相关论文
共 28 条
[1]   The Antiangiogenic Activity in Xenograft Models of Brivanib, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinases [J].
Bhide, Rajeev S. ;
Lombardo, Louis J. ;
Hunt, John T. ;
Cai, Zhen-wei ;
Barrish, Joel C. ;
Galbraith, Susan ;
Jeyaseelan, Robert, Sr. ;
Mortillo, Steven ;
Wautlet, Barri S. ;
Krishnan, Bala ;
Kukral, Daniel ;
Malone, Harold ;
Lewin, Anne C. ;
Henley, Benjamin J. ;
Fargnoli, Joseph .
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (02) :369-378
[2]   Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer [J].
Brooks, A. Nigel ;
Kilgour, Elaine ;
Smith, Paul D. .
CLINICAL CANCER RESEARCH, 2012, 18 (07) :1855-1862
[3]   Oncomirs - microRNAs with a role in cancer [J].
Esquela-Kerscher, A ;
Slack, FJ .
NATURE REVIEWS CANCER, 2006, 6 (04) :259-269
[4]   MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1 [J].
He, Xinxin ;
Wei, Yangnian ;
Wang, Yong ;
Liu, Ling ;
Wang, Wen ;
Li, Nianfeng .
ONCOTARGETS AND THERAPY, 2016, 9 :1231-1239
[5]  
Hu J, 2016, AM J TRANSL RES, V8, P3023
[6]   Gene silencing by microRNAs: contributions of translational repression and mRNA decay [J].
Huntzinger, Eric ;
Izaurralde, Elisa .
NATURE REVIEWS GENETICS, 2011, 12 (02) :99-110
[7]   miR-29b suppresses proliferation, migration, and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1 [J].
Jia, Ling-Fei ;
Huang, Yi-Ping ;
Zheng, Yun-Fei ;
Lyu, Ming-Yue ;
Wei, Su-Bi ;
Meng, Zhen ;
Gan, Ye-Hua .
ORAL ONCOLOGY, 2014, 50 (11) :1062-1071
[8]   Prognostic Implications of MicoRNA miR-195 Expression in Human Tongue Squamous Cell Carcinoma [J].
Jia, Ling-fei ;
Wei, Su-bi ;
Gong, Kai ;
Gan, Ye-hua ;
Yu, Guang-yan .
PLOS ONE, 2013, 8 (02)
[9]   FGFR2-related pathogenesis and FGFR2-targeted therapeutics [J].
Katoh, Yuriko ;
Katoh, Masaru .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (03) :307-311
[10]   miR-1271 inhibits OSCC cell growth and metastasis by targeting ALK [J].
Kong, D. J. ;
Wang, J. ;
Ma, H. Q. ;
Jiang, G. Y. .
NEOPLASMA, 2015, 62 (04) :559-566